Huntington National Bank raised its stake in shares of CVS Health Corporation (NYSE:CVS) by 3.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 450,578 shares of the pharmacy operator’s stock after buying an additional 13,312 shares during the period. Huntington National Bank’s holdings in CVS Health Corporation were worth $40,096,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in CVS. East Coast Asset Management LLC. increased its stake in CVS Health Corporation by 0.3% in the second quarter. East Coast Asset Management LLC. now owns 2,431 shares of the pharmacy operator’s stock worth $233,000 after buying an additional 7 shares during the period. Valley National Advisers Inc. increased its stake in CVS Health Corporation by 0.5% in the second quarter. Valley National Advisers Inc. now owns 1,790 shares of the pharmacy operator’s stock worth $171,000 after buying an additional 9 shares during the period. Signature Financial Management Inc. increased its stake in shares of CVS Health Corporation by 0.3% in the third quarter. Signature Financial Management Inc. now owns 3,400 shares of the pharmacy operator’s stock valued at $303,000 after buying an additional 9 shares during the last quarter. Lourd Capital LLC increased its stake in shares of CVS Health Corporation by 0.3% in the second quarter. Lourd Capital LLC now owns 3,598 shares of the pharmacy operator’s stock valued at $344,000 after buying an additional 11 shares during the last quarter. Finally, Thompson Davis & CO. Inc. increased its stake in shares of CVS Health Corporation by 0.5% in the second quarter. Thompson Davis & CO. Inc. now owns 2,606 shares of the pharmacy operator’s stock valued at $249,000 after buying an additional 14 shares during the last quarter. Hedge funds and other institutional investors own 80.44% of the company’s stock.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.35% during trading on Tuesday, reaching $75.04. The company had a trading volume of 774,505 shares. The firm has a 50-day moving average of $81.47 and a 200-day moving average of $91.44. CVS Health Corporation has a 12-month low of $69.30 and a 12-month high of $106.67. The company has a market cap of $80.03 billion, a P/E ratio of 16.08 and a beta of 0.88.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.57 by $0.07. The company had revenue of $44.60 billion for the quarter, compared to the consensus estimate of $45.29 billion. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. The firm’s revenue was up 15.5% compared to the same quarter last year. During the same period last year, the business posted $1.28 earnings per share. On average, equities research analysts anticipate that CVS Health Corporation will post $5.81 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Thursday, November 3rd. Investors of record on Monday, October 24th were given a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend was Thursday, October 20th. CVS Health Corporation’s dividend payout ratio (DPR) is presently 36.40%.

WARNING: This piece was originally published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright laws. The original version of this piece can be accessed at https://www.thecerbatgem.com/2016/11/29/huntington-national-bank-has-40096000-position-in-cvs-health-corporation-cvs.html.

Several equities research analysts have recently weighed in on CVS shares. FBR & Co reaffirmed an “outperform” rating and issued a $120.00 target price on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Zacks Investment Research raised CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 3rd. Deutsche Bank AG upped their target price on CVS Health Corporation from $99.00 to $108.00 and gave the stock a “hold” rating in a research report on Wednesday, August 3rd. Morgan Stanley reaffirmed a “hold” rating and issued a $104.00 target price on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Finally, Leerink Swann reaffirmed a “buy” rating on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. CVS Health Corporation currently has a consensus rating of “Buy” and an average price target of $106.24.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.